Post-transplantation cyclophosphamide
Showing 26 - 50 of >10,000
Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, MDS Trial in Saint Petersburg (Bendamustine Hydrochloride, Cyclophosphamid)
Recruiting
- Myeloid Leukemia, Acute
- +3 more
- Bendamustine Hydrochloride
- Cyclophosphamid
-
Saint Petersburg, Russian FederationRM Gorbacheva Research Institute
Apr 4, 2022
GVHD Trial in New York (Bortezomib, Cyclophosphamide)
Active, not recruiting
- GVHD
-
New York, New YorkNew York University School of Medicine
Apr 15, 2022
Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)
Recruiting
- Graft Vs Host Disease
- Cyclophosphamide
- +2 more
-
New York, New YorkNYU Langone Health
Nov 10, 2022
Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation Trial (haplo-SCT with PTCy)
Not yet recruiting
- Hematologic Diseases
- +2 more
- haplo-SCT with PTCy
- (no location specified)
Nov 8, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)
Recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Cyclophosphamide
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Trial (Allogenic
Not yet recruiting
- Refractory Idiopathic Aplastic Anemia
- Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
- Allogenic transplantation
- (no location specified)
Nov 8, 2021
Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival Trial in Canada, United States (drug,
Completed
- Myeloablative Conditioning
- +3 more
- Cyclophosphamide
- +5 more
-
Aurora, Colorado
- +8 more
Nov 23, 2021
Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, Bortezomib)
Recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +2 more
-
New York, New YorkNYU Langone Health
Mar 24, 2022
Acute Leukemia, MDS Trial in Chicago (device, drug, other)
Recruiting
- Acute Leukemia
- MDS
- Arm1
- Arm 1
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Oct 13, 2022
Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)
Active, not recruiting
- Graft-versus-host Disease
- Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
-
New York, New YorkNYU Langone Health
Aug 5, 2022
Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)
Recruiting
- Hematological Malignancies
- Total Body Irradiation
- +6 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 4, 2022
GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)
Active, not recruiting
- Graft Versus Host Disease
- Hematopoietic/Lymphoid Cancer
- fludarabine phosphate
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Acute Myeloid Leukemia Trial in Duarte (procedure, drug, biological, other, radiation)
Recruiting
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 8, 2022
Leukemia, Myeloid, Acute, MDS, Myelodysplastic Syndrome Acute Myeloid Leukemia Trial in Denver (Nivolumab)
Withdrawn
- Leukemia, Myeloid, Acute
- +2 more
-
Denver, ColoradoColorado Blood Cancer Institute
Apr 20, 2021
Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Westwood (EAGD T-cell infusion (Phase
Recruiting
- Acute Myeloid Leukemia
- +3 more
- EAGD T-cell infusion (Phase I)
- EAGD T-cell infusion (Expansion)
-
Westwood, KansasUniversity of Kansas Cancer Center
Mar 15, 2022
GVHD, Acute Trial in Shanghai (PT-CY-FK +/-ATG)
Completed
- GVHD, Acute
- PT-CY-FK +/-ATG
-
Shanghai, Shanghai, ChinaRui Jin Hospital
May 19, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 1, 2022
Hematopoietic Stem Cell Transplantation Trial in Beijing (post-transplantation cyclophosphamide)
Completed
- Hematopoietic Stem Cell Transplantation
- post-transplantation cyclophosphamide
-
Beijing, ChinaPeking University People's Hospital
Sep 15, 2020
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Hematopoietic Stem Cell Transplantation Trial (Drug: Cyclophosphamide)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Drug: Cyclophosphamide
- (no location specified)
Jun 22, 2021
Bone Marrow Transplant Infection, Bone Marrow Transplant Complications, Graft Vs Host Disease Trial in Rozzano (modified donor
Completed
- Bone Marrow Transplant Infection
- +4 more
- modified donor lymphocytes infusion (mDLI)
-
Rozzano, MI, ItalyIstituto Clinico Humanitas
Dec 24, 2020
Cytomegalovirus Infection After HSCT and PT-CY as GVHD
Completed
- CMV Infection
-
Malaga, SpainMaria Jesus Pascual
Mar 30, 2022
Immunodeficiency, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute (NCI) (drug, radiation,
Recruiting
- Immunodeficiency
- Hematopoietic Stem Cell Transplantation
- Post-Transplant Cyclophosphamide (PTCY)
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022